CHINA BIOLOGIC PRODS HLDGS I's ticker is and the CUSIP is G21515904. A total of 2 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $22,000 | -69.4% | 200 | -71.4% | 0.00% | – |
Q2 2020 | $72,000 | -95.6% | 700 | -95.0% | 0.00% | -100.0% |
Q4 2019 | $1,629,000 | -68.4% | 14,000 | -69.0% | 0.01% | -73.8% |
Q3 2019 | $5,163,000 | +5.6% | 45,100 | -12.1% | 0.04% | -4.5% |
Q2 2019 | $4,889,000 | +183.4% | 51,300 | +171.4% | 0.04% | +131.6% |
Q1 2019 | $1,725,000 | -4.1% | 18,900 | -20.3% | 0.02% | +18.8% |
Q4 2018 | $1,799,000 | +42.3% | 23,700 | +50.0% | 0.02% | +60.0% |
Q3 2018 | $1,264,000 | +409.7% | 15,800 | +532.0% | 0.01% | +400.0% |
Q2 2018 | $248,000 | – | 2,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SIMPLEX TRADING, LLC | 118 | $1,273,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |